Oncologist
Tom A. John
Melbourne
Quick Appointment for Tom A. John
No OPD information available
Services Offered by Tom A. John
Lung Cancer
Non-Small Cell Lung Cancer (NSCLC)
EGFR Positive Lung Cancer
Lung Metastases
Mesothelioma
Squamous Cell Lung Carcinoma
About Of Tom A. John
Tom A. John is a male doctor who helps people with lung cancer. He specializes in different types of lung cancer like Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Mesothelioma. He also treats conditions like Lung Metastases and Squamous Cell Lung Carcinoma.
Dr. Tom A. John is very skilled in treating lung cancer patients. He uses special treatments to help them get better. Patients trust him because he communicates well with them. He explains things in a way they can understand and listens to their concerns.
Dr. Tom A. John stays updated with the latest medical knowledge and research. This helps him give the best care to his patients. He works closely with other doctors and medical professionals to provide comprehensive care.
Dr. Tom A. John has made a positive impact on many patients' lives. His work has helped people improve their health and fight against lung cancer. He has also published important research in medical journals, showing his dedication to advancing the field of oncology.
One of his notable publications is about the ethical evaluation of precision oncology approaches in NSCLC. Dr. Tom A. John has also been involved in clinical trials to study new treatments for EGFR mutant advanced stage NSCLC. These trials help find better ways to treat lung cancer and improve patient outcomes.
In summary, Dr. Tom A. John is a dedicated and skilled doctor who specializes in treating lung cancer. He is committed to staying updated with the latest research and works collaboratively with other medical professionals to provide the best care for his patients. His work has had a positive impact on many lives, and he continues to contribute to the field of oncology through his research and clinical trials.
Publications by Tom A. John
Clinical Trials by Tom A. John
A Phase I/II, Open-Label, Multicentre Study to Investigate the Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AZD4205 as Monotherapy or in Combination With Osimertinib in Patients With EGFR Mutant Advanced Stage Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Completed
Published: August 24, 2020
Intervention Type: Drug
Study Drug:
Study Phase: Phase 1/Phase 2
Frequently Asked Questions About Tom A. John
What conditions does Tom A. John specialize in as an Oncologist?
What services does Tom A. John offer to cancer patients?
How does Tom A. John approach personalized treatment plans for cancer patients?
What are some common side effects of cancer treatments that patients may experience?
How does Tom A. John support cancer patients and their families throughout the treatment journey?
What should patients do if they have concerns about their cancer diagnosis or treatment plan?
More Oncologist Like Tom A. John in Melbourne
